Company intelligence / Profile preview

Biomark Oncology

Richmond, British Columbia, Canadawebfiles.thecse.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Develops liquid biopsy tests using metabolomics and machine learning for early cancer detection, with recent publications demonstrating breast cancer screening capabilities and NEN biomarker identification[4][3].

Therapeutic areas: Oncology
Modalities: Liquid biopsy diagnostics
Industry: Metabolite Diagnostics

Partnerships

Unspecified academic collaborators (implied by published research)[4]

Beyond the preview

Go deeper on Biomark Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomark Oncology.

Explore the full profile